These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8138670)

  • 21. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.
    Boukerb AM; Rousset A; Galanos N; Méar JB; Thépaut M; Grandjean T; Gillon E; Cecioni S; Abderrahmen C; Faure K; Redelberger D; Kipnis E; Dessein R; Havet S; Darblade B; Matthews SE; de Bentzmann S; Guéry B; Cournoyer B; Imberty A; Vidal S
    J Med Chem; 2014 Dec; 57(24):10275-89. PubMed ID: 25419855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
    Matsumoto K
    Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
    J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa.
    Kondoh K; Hashiba M; Baba S
    Acta Otolaryngol Suppl; 1996; 525():56-60. PubMed ID: 8908271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
    Nagata T; Mukae H; Kadota J; Hayashi T; Fujii T; Kuroki M; Shirai R; Yanagihara K; Tomono K; Koji T; Kohno S
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2251-9. PubMed ID: 15155229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.
    Liu Z; Lin Y; Lu Q; Li F; Yu J; Wang Z; He Y; Song C
    Infection; 2017 Feb; 45(1):23-31. PubMed ID: 27189338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa].
    Yanagihara K; Tomono K; Sawai T; Sasaki E; Kakeya H; Yamamoto Y; Ohno H; Ogawa K; Kadota J; Koga H; Kohno S; Hirakata Y; Tashiro T
    Kansenshogaku Zasshi; 1997 Apr; 71(4):337-41. PubMed ID: 9164089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.
    Yasuda H; Ajiki Y; Koga T; Kawada H; Yokota T
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1749-55. PubMed ID: 8239580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
    Mikuniya T; Kato Y; Ida T; Maebashi K; Monden K; Kariyama R; Kumon H
    J Infect Chemother; 2007 Oct; 13(5):285-90. PubMed ID: 17982715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
    Ding FM; Zhu SL; Shen C; Jiang YQ
    Respirology; 2012 May; 17(4):727-34. PubMed ID: 22404374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system.
    Komor U; Bielecki P; Loessner H; Rohde M; Wolf K; Westphal K; Weiss S; Häussler S
    Microbes Infect; 2012 Sep; 14(11):951-8. PubMed ID: 22542841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
    Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
    Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.